ClearPoint Neuro (CLPT) Return on Sales (2011 - 2026)

ClearPoint Neuro has disclosed Return on Sales across 15 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at ClearPoint Neuro, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2024 to a low of 0.01% in Q2 2023.
• The 5-year median for Return on Sales is 0.01% (2022), against an average of 0.01%.
• Across the five-year window, Return on Sales changed 0 bps in 2022 and grew 1 bps in 2024, its largest moves.
• ClearPoint Neuro's Return on Sales stood at 0.01% in 2022, then gained by 20 bps to 0.01% in 2023, then fell by 0 bps to 0.01% in 2024, then fell by 8 bps to 0.01% in 2025, then declined by 5 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.